Abstract

BackgroundWe conducted a cohort study to compare the characteristics of MDR-TB with non-MDR-TB patients and to measure long term (9-year) mortality rate and determine factors associated with death in China.MethodsWe reviewed the medical records of 250 TB cases from a 2001 survey to compare 100 MDR-TB patients with 150 non-MDR-TB patients who were treated in 2001-2002. Baseline attributes extracted from the records were compared between the two cohorts and long-term mortality and risk factors were determined at nine-year follow-up in 2010.ResultsAmong the 234 patients successfully followed up, 63 (26.9%) were female and 171 (73.1 %) were male. MDR-TB patients had poorer socioeconomic status compared to non-MDRTB. Nine years after the diagnosis of TB, 69 or 29.5 % of the 234 patients had died (32 or 21.6 % of non-MDR-TB versus 37 or 43.0 % of MDR-TB) and the overall mortality rate was 39/1000 per year (PY) (27/1000 PY among non-MDR versus 63/1000 PY among MDR-TB). Factors associated with death included: MDR status (hazard ratio (HR): 1.86; CI: 1.09-3.13), limited education of primary school or lower (HR: 2.51; CI 1.34-4.70) and received TB treatment during the nine-year period (HR 1.82; 95 % CI 1.02-3.26).ConclusionsMDR-TB was a strong predictor for poor long-term outcome. High quality diagnosis and treatment must be ensured. Greater reimbursement or free treatment may be needed to provide access for the poor and vulnerable populations, and to increase treatment compliance.

Highlights

  • We conducted a cohort study to compare the characteristics of Multidrug-resistant tuberculosis (MDR-TB) with non-MDR-TB patients and to measure long term (9-year) mortality rate and determine factors associated with death in China

  • Most were married and there was no significant difference in marital status between the MDR and non-MDR-TB groups

  • We found that patients with MDR-TB had poorer outcomes than non-MDR-TB patients

Read more

Summary

Introduction

We conducted a cohort study to compare the characteristics of MDR-TB with non-MDR-TB patients and to measure long term (9-year) mortality rate and determine factors associated with death in China. Despite impressive reductions in TB prevalence and mortality over the past 20 years, the World Health Organization (WHO) estimates that China has the second largest number of MDR-TB cases globally; only India has more cases [2]. MDR-TB requires prolonged treatment with costly second-line anti-TB drugs (SLD), leading to health system opportunity costs, adverse effects, and financial impacts for patients [4,5,6]. Recurrence and treatment failure are more common for drug resistant than drug sensitive TB [8,9,10], little is known of the impact of multidrug resistance on long-term mortality and survival

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.